Compare AFBI & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AFBI | TKNO |
|---|---|---|
| Founded | 1928 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 136.0M | 138.1M |
| IPO Year | 2020 | 2021 |
| Metric | AFBI | TKNO |
|---|---|---|
| Price | $22.36 | $2.75 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 33.2K | ★ 107.1K |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 55.42 | 43.86 |
| EPS | ★ 1.29 | N/A |
| Revenue | N/A | ★ $40,520,000.00 |
| Revenue This Year | N/A | $8.27 |
| Revenue Next Year | N/A | $13.13 |
| P/E Ratio | $17.36 | ★ N/A |
| Revenue Growth | N/A | ★ 7.35 |
| 52 Week Low | $17.75 | $1.91 |
| 52 Week High | $22.47 | $7.48 |
| Indicator | AFBI | TKNO |
|---|---|---|
| Relative Strength Index (RSI) | 72.15 | 47.59 |
| Support Level | $18.61 | $2.55 |
| Resistance Level | N/A | $3.24 |
| Average True Range (ATR) | 0.19 | 0.25 |
| MACD | 0.14 | -0.02 |
| Stochastic Oscillator | 96.91 | 28.17 |
Affinity Bancshares Inc is a bank holding company. The bank provides a range of financial services, including checking and savings accounts, certificates of deposit, mortgage, commercial and consumer loans, and money transfer services, operating across parts of Georgia and offering specialized lending such as dental practice and indirect automobile loans across the Southeastern United States. Its business mainly involves accepting public deposits and investing them in real estate and commercial loans, as well as mortgage-backed securities. The company also gathers deposits nationwide through its virtual bank, FitnessBank, and uses additional funding sources such as Federal Home Loan Bank borrowings.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.